Dr. Mary Teeling

Adjunct Assistant Professor (p/t), Pharmacology & Therapeutics

teelinm@tcd.ie http://people.tcd.ie/teelinm

Biography

I am a specialist pharmaceutical physician with extensive experience in the areas of pharmacology and pharmaceutical medicine. In addition to my role as Assistant Professor, in the School of Medicine, Trinity College Dublin, I also work in the National Medicines Information Centre (NMIC) as a part-time medical advisor. I worked in the national regulatory authority (Irish Medicines Board) for 12 years and served as its medical director from 1995-2000. I was a member of the European scientific committee (Committee for Human Medicinal Products) from 1994-2000 and was appointed to the role of vice-chairman in 1998 until 2000. In my role as medical advisor in the NMIC, I am the co-author of the NMIC publications Therapeutics Today and NMIC Bulletin, which provide updates on therapeutic topics to primary care physicians and other healthcare professionals. I was part of the education team that developed the higher specialist training (HST) programme in Pharmaceutical Medicine, in conjunction with the Royal College of Physicians in Ireland (RCPI). I am currently the National Specialty Director for Pharmaceutical Medicine and a member of the Irish Committee for Higher Medical Training (ICHMT) in RCPI.

Publications and Further Research Outputs

Peer-Reviewed Publications
Non-Peer-Reviewed Publications

Cooper JA, Ryan C, Smith SM, Wallace E, Bennett K, Cahir C, Williams D, Teeling M, Fahey T, Hughes CM; (The PROMPT Steering Group) , The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria., BMC Health Services Research, 14, 2014, p13Journal Article, 2014
Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Hughes CM., Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria., European Journal of Clinical Pharmacology, 72, (5), 2016, p583 - 591Journal Article, 2016
Teeling M, MacAvin M, Bennett K, Impact of safety warnings on domperidone prescribing in Ireland, Irish Journal of Medical Science, 2017, p5Journal Article, 2017, URL
K. Bennett, M. Teeling and J. Feely, Selective switching from non-selective to selective non-steroidal anti-inflammatory drugs, European Journal of Clinical Pharmacology, 59, (38238), 2003, p645-9Journal Article, 2003, URL
M. Savage, M. Teeling, K. Bennett and J. Feely, Adherence to clinical guidance in the prescribing of anticoagulant medication in patients with atrial fibrillation, British Journal of Clinical Pharmacology, 59, 2005, 646Meeting Abstract, 2005
Teeling M, Bennett K, Feely J. , Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs., British Journal of Clinical Pharmacology, 57, 2004, p337 - 343Journal Article, 2004
Teeling M, Bennett K, Feely J., The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002., British Journal of Clinical Pharmacology, 59, 2005, p227 - 232Journal Article, 2005
Bennett K, Teeling M, Feely J., "Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs, Eur J Clin Pharmacol., 59, (8-9), 2003, p645 - 649Journal Article, 2003
M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ? , British Journal of Clinical Pharmacology, 55, 2003, 419Meeting Abstract, 2003
McGing P., Daly R., Teeling M., Kyne F., Carney D.N., Serum TPS (TPA) and CA125 as prognostic markers in ovarian cancer, Proc Nat. Meeting of Assoc. of Clin Biochem., 1994Journal Article, 1994
Teeling M., Hayes Y., Fitzmaurice B., McGing P., Carney D.N., Carboplatin / Cyclophosphamide Combination Chemotherapy for advanced ovarian cancer, Seminars Oncol., 19, (1(Suppl. 2)1), 1992, p102 - 106Journal Article, 1992
Teeling M., Carney D.N., Phase II study of carboplatin and cyclophosphamide combination chemotherapy for the treatment of advanced ovarian cancer, Eur. J of Gynaecol Oncol, 11, (3), 1990, p219 - 224Journal Article, 1990
Carboplatin plus cyclophosphamide for epithelial ovarian cancer in, editor(s)P.A. Bunn Jr., R., Cannetta, R.F. Ozols, M. Rozencwieg , Carboplatin (JM8) Current perspectives and future directions, W.B. Saunders Company, 1990, [Carney D.N., Teeling M.]Book Chapter, 1990
McGing P.G., Teeling M., McCann A., Kyne F, Carney D.N., Non-MCK - a practical measure of creatinine kinase in cancer patients, Clin Chim Acta, 187, (3), 1990, p309 - 315Journal Article, 1990
Teeling M., McGing P., Johnston P., Carney D.N., Clinical Correlation of Tumor Endocrine Markers in Lung in cancer, Cancer Treat Res, 45, 1989, p137 - 149Journal Article, 1989
Teeling M, McGing P, Carney DN, The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer, Ir. J. Med. Sci, 58, (3), 1989, p59 - 62Journal Article, 1989
Teeling M., Carney D., Casey B., Pratt I. and Ryan M.P., Comparison of the effects of cisplatin and carboplatin on magnesium status in cancer patients, Magnesium Research, 2, 1989, p101 - 101Journal Article, 1989
Splinter T.A.W., Carney D.N., Teeling M. Peake M.D., Kho GS, Oosterom R. and Cooper E.J., Neuron-Specific enolase can be used as the sole guide to treat small cell lung cancer patients, J. Cancer Res. Clin. Oncology, 115, (4), 1989, p400 - 401Journal Article, 1989
Biochemical Markers of lung cancer in, editor(s)S. Rosen, J. Mulshine, F. Cuttita, P.G. Abrams , Biology of lung cancer: Diagnosis and Treatment, Marcel Dekker Inc., 1988, [Teeling M. and Carney D.N.]Book Chapter, 1988
Carney D.N, Teeling M., Neuron-Specific Enolase: How useful as a Cancer Maker?, Eur. J. Cancer Clin. Oncol., 24, (5), 1988, p825 - 828Journal Article, 1988
Splinter TA, Carney DN, Teeling M, Oosterom R., Levels of Neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer, J. Cancer Res Clin Oncol, 114, (6), 1988, p641 - 643Journal Article, 1988
O'Neill H, Teeling M, Carney DN, Ennis JT., Abdominal computed tomography in patients with small cell lung cancer, Ir. J. Med Sci, 157, (11), 1988, p344 - 347Journal Article, 1988
Teeling M., Carney D.N., Carboplatin and cyclophosphamide combination chemotherapy in advanced ovarian cancer, Proc. Amer Soc. Clin. Oncol., 6, 1987, p458 - 458Journal Article, 1987
Burke, E, Teeling M, Carney D, Eustace P., The Retinotoxic Effects of Oncological Agents, Bull Soc. Belge Ophthalmol, 224, 1987, p77 - 79Journal Article, 1987
Teeling M., Casey B., Carney D.N., Pratt I. and Ryan M.P., Differential nephrotoxicity of cisplatin and carboplatin, Clinical Science, 71, (suppl. 15), 1986, p76 - 76Journal Article, 1986
Teeling M., Casey B., Pratt I., Ryan M.P. and Carney D.N., N-acetyl-B-glucosaminidase (B Nag) as an early predictor of renal tubular dysfunction in cisplatin nephrotoxicity, Proc. Am. Soc. Clin Oncol., 5, 1986, p204 - 204Journal Article, 1986
Dervan P., Teeling M., Dempsey J., Drury M., Murphy J., O'Malley E. and O'Connell D., Lymphadenopathy due to fatal histiocytic proliferative disorder containing Michaelis-Gutmann Bodies, Cancer, 57, (7), 1986, p1337 - 1340Journal Article, 1986
Teeling M., Conlon D., Pratt I., Carney D.N. and Ryan M.P., Prospective investigation of Cisplatin-induced nephrotoxicity including renal magnesium wasting in cancer patients, J. American College Nutrition, 5, 1985, p1489 - 1489Journal Article, 1985
Robinson A.C.R., Teeling M. and Casey E.B., Hepatic function in ankylosing spondylitis, Annals of Rheumatic diseases, 42, (5), 1983, p550 - 552Journal Article, 1983
Robinson A. and Teeling M., Angioneurotic oedema and urticaria induced by hyoscine butyl bromide, Post Graduate Medical Journal, 58, (679), 1982, p316 - 316Journal Article, 1982
Robinson A., Dockery J., Teeling M., Peacock A. and Casey E., Gonococcal arthritis in pregnancy: A report of two cases, Irish Journal of Medical Science, 151, (10), 1982, p313 - 314Journal Article, 1982
M. Teeling, J. Feely, Adverse drug reactions: reducing the risk in older people, Prescriber, 5, 2005, p12 - 19Journal Article, 2005
M. Savage, M. Teeling, K. Bennett, J. Feely, Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation, Irish Journal of Medical Science, 175, (2), 2006, p46 - 49Journal Article, 2006
K. Bennett, M. Teeling, J. Feely, Overprescribing antidepressants to children: pharmacoepidemiological study in, British Medical Journal, 331, 2005, p1451 - 1452Journal Article, 2005
C. Usher, M. Teeling, K. Bennett, B. McGowan, J. Feely, Usage of paracetamol-containing combination analgesics remains high in primary, British Journal of Clinical Pharmacology, 60, (6), 2005, p648 - 652Journal Article, 2005
C. Usher, M. Teeling, K. Bennett, J. Feely, Effect of clinical trial publicity on HRT prescribing in Ireland, European Journal of Clinical Pharmacology, 1, 2006, p4Journal Article, 2006
M. Teeling, K. Bennett, J. Feely, What therapies have replaced Rofecoxib, Pharmacoepidemiology and Drug Safety, 15, 2006, S46Journal Article, 2006
M. Teeling, K. Bennett, H. O'Connor, J. Feely, How did the withdrawal of rofecoxib impact on prescribing of non-steroidal anti-inflammatory drugs ?, British Journal of Clinical Pharmacology, 61, 2006, pp637 - 638Meeting Abstract, 2006
M. Teeling, H. O'Connor, J. Feely, K. Bennett, What therapies have replaced rofecoxib in Ireland ?, British Journal of Clinical Pharmacology, 64, (4), 2007, p536 - 541Journal Article, 2007
O'Shea M, Teeling M, Bennett K, The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: A retrospective cross-sectional study using a national pharmacy claims database., BMC health services research, 13, 2013, p23Journal Article, 2013, DOI , TARA - Full Text
O'Shea MP, Teeling M, Bennett K., Comorbidity, health-related quality of life and self-care in type 2 diabetes: a cross-sectional study in an outpatient population., Irish Journal of Medical Science, 184, (3), 2015, p623 - 630Journal Article, 2015
O'Shea MP, Teeling M, Bennett K., Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland, Irish Journal of Medical Science, 184, (2), 2015, p403 - 410Journal Article, 2015
O'Shea MP, Teeling M, Bennett K., An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents., Pharmacoepidemiology and Drug Safety, 12, 2013, p1336 - 1344Journal Article, 2013
Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K, , Potentially inappropriate prescribing and cost outcomes for older people: a national population study, British Journal of Clinical Pharmacology, 69, 2010, p542 - 552Journal Article, 2010

M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ?, British Journal of Clinical Pharmacology, 55, 2004, 419Meeting Abstract
Teeling M., "Use of Lofexidine and Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003Report
Teeling M., "Use of Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003Report
Teeling M., "Use of Buprenorphine as an intervention in the treatment of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2002Report
Teeling M., Licensing of Vaccines, Forum, 17, (7), 2000, p39 - 41Journal Article
Teeling M, The European Regulatory Perspective: Scientific Advice, Int J. Pharm Med, 13, 1999, p92 - 92Journal Article
Teeling M, Immunisation: New developments in vaccines, Modern Medicine, 27, (10), 1997, p67 - 68Journal Article
Teeling M., Initial Experiences with the New European Regulatory Procedures, J. Eur Soc Reg Affairs, 3, (3), 1996, p53 - 54Journal Article
M. Teeling, J. Feely, Prevention of NSAID side effects, Clinical Focus (Forum), 5, (4), 2005, p4 - 6Journal Article
Pharmacovigilance and Risk Management in, editor(s)A C Cartwright, B R Matthews , International Pharmaceutical Product Registration, , United Kingdom, Informa Healthcare, 2009, [Informa Healthcare]Book Chapter

. Clinical Pharmacology . Pharmaceutical Medicine . Clinical Oncology . Pharmacoepidemiology

Pharmacology & Toxicology including drug formulation and delivery, Pharmacology & Toxicology including drug formulation and delivery, Population Health, Public & Environment Health, Oncology and cancer biology, Oncology and cancer biology, Population Health, Public & Environment Health,

Recognition

1999 Outstanding Service Award - Drug Information Association (DIA). 1999

Association of Pharmaceutical Physicians of Ireland (APPI)
International Society of Pharmacoepidemiology
Royal Academy of Medicine in Ireland (fellow)
Royal College of Physicians of Ireland (Fellow)

EU member of the Steering Committee on International Conference on Harmonisation (ICH) 1999-2000
National Specialty Director, Pharmaceutical Medicine, Royal College of Physicians of Ireland. 2013-
Former chairman of the Scientific Advice Working Party, European Medicines Agency 1998-2000
Vice chairman of the Committee for Proprietary Medicinal Products (CPMP, European Medicines Agency 1998-2000
EU member of the Steering Committee on International Conference on Harmonisation (ICH) 1999-2000
Former chairman of the Scientific Advice Working Party, European Medicines Agency 1998-2000
Vice chairman of the Committee for Proprietary Medicinal Products (CPMP, European Medicines Agency 1998-2000
Former chairman of the CPMP ad hoc committee on anti-cancer agents 1997-2000
National Specialty Director, Pharmaceutical Medicine, Royal College of Physicians of Ireland. 2013-
Former chairman of the CPMP ad hoc committee on anti-cancer agents 1997-2000